2370.T Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 02:15):

MEDINET Co., Ltd. operates as a contract development and manufacturing organization that provides regenerative medicine and cell therapy solutions in Japan...

Stats
Today's Volume	856 900
Average Volume	1.40M
Market Cap	11.53B
EPS	¥0 ( 2024-02-08 )
Next earnings date	( ¥0 ) 2024-05-08
Last Dividend	¥0 ( N/A )
Next Dividend	¥0 ( N/A )
P/E	-7.13
ATR14	¥0.147 (0.32%)

Volume Correlation

Long: 0.09 (neutral)

Short: -0.31 (neutral)

Signal:(54.146) Neutral

MEDINET Co., Ltd. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

MEDINET Co., Ltd. Correlation - Currency/Commodity

-0.02
( neutral )

-0.01
( neutral )

0.00
( neutral )

-0.05
( neutral )

-0.26
( neutral )

0.45
( neutral )

MEDINET Co., Ltd. Financials

Annual	2023
Revenue:	¥661.54M
Gross Profit:	¥98.25M (14.85 %)
EPS:	¥-6.65

Q1	2024
Revenue:	¥248.24M
Gross Profit:	¥76.39M (30.77 %)
EPS:	¥-1.200

Q4	2023
Revenue:	¥169.62M
Gross Profit:	¥28.20M (16.62 %)
EPS:	¥-1.750

Q3	2023
Revenue:	¥142.51M
Gross Profit:	¥1.94M (1.36 %)
EPS:	¥-1.700

Financial Reports:

No articles found.

MEDINET Co., Ltd.

MEDINET Co., Ltd. operates as a contract development and manufacturing organization that provides regenerative medicine and cell therapy solutions in Japan. Its solutions include technical know-how, facilities, systems, materials, professional cell-engineers, and other requirements to conduct immuno-cell therapy. The company also manufactures regenerative medical/investigational and specified cell products. In addition, its value chain solutions include personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management system, quality control and assurance, and technology transfer and process development solutions. Further, the company supports medical institutions, research institutions, and biopharmaceutical companies to conduct immuno-cell therapy. MEDINET Co., Ltd. was incorporated in 1995 and is headquartered in Tokyo, Japan.